S
Sourour Mansour
Researcher at Necker-Enfants Malades Hospital
Publications - 3
Citations - 1053
Sourour Mansour is an academic researcher from Necker-Enfants Malades Hospital. The author has contributed to research in topics: Gene & Chemistry. The author has an hindex of 2, co-authored 2 publications receiving 898 citations.
Papers
More filters
Journal ArticleDOI
Interleukin-36–Receptor Antagonist Deficiency and Generalized Pustular Psoriasis
Slaheddine Marrakchi,Philippe Guigue,Blair R. Renshaw,Anne Puel,Xue-Yuan Pei,Sylvie Fraitag,Jihen Zribi,Elodie Bal,Céline Cluzeau,Maya Chrabieh,Jennifer E. Towne,Jason Douangpanya,Christian Pons,Sourour Mansour,Valérie Serre,Hafedh Makni,Nadia Mahfoudh,Faiza Fakhfakh,Christine Bodemer,Josué Feingold,Smail Hadj-Rabia,Michel Favre,Emmanuelle Génin,Mourad Sahbatou,Arnold Munnich,Jean-Laurent Casanova,John E. Sims,Hamida Turki,Hervé Bachelez,Asma Smahi +29 more
TL;DR: Aberrant interleukin-36Ra structure and function lead to unregulated secretion of inflammatory cytokines and generalized pustular psoriasis.
Journal ArticleDOI
Only four genes (EDA1, EDAR, EDARADD, and WNT10A) account for 90% of hypohidrotic/anhidrotic ectodermal dysplasia cases.
Céline Cluzeau,Smail Hadj-Rabia,Marguerite Jambou,Sourour Mansour,Philippe Guigue,Sahben Masmoudi,Elodie Bal,Nicolas Chassaing,Marie-Claire Vincent,Géraldine Viot,François Clauss,Marie-Cécile Manière,Steve Toupenay,Martine Le Merrer,Stanislas Lyonnet,Valérie Cormier-Daire,Jeanne Amiel,Laurence Faivre,Yves de Prost,Arnold Munnich,Jean-Paul Bonnefont,Christine Bodemer,Asma Smahi +22 more
TL;DR: Although no clinical differences between patients carrying EDA1, EDAR, or EDARADD mutations could be identified, patients harboring WNT10A mutations displayed distinctive clinical features, helping to decide which gene should be first investigated in HED/EDA.
Journal ArticleDOI
Identification of a novel peptide ligand for the cancer-specific receptor mutation EGFRvIII using high-throughput sequencing of phage-selected peptides
Sourour Mansour,Indranil Adhya,Coralie Lebleu,Ramakrishna Dumpati,Ahmed M Rehan,Santu Chall,Jian-Guo Dai,Gauthier Errasti,Thomas Delacroix,Raj Chakrabarti +9 more
TL;DR: In this paper , a novel peptide ligand using phage display targeted against the cancer-specific epidermal growth factor tyrosine kinase receptor mutation variant III (EGFRvIII) was presented.